Showing all 2 results

Emjard 10

250.00৳ Strip
  • Emjard, an SGLT-2 inhibitor, empowers glycemic control and reduces cardiovascular risks in adults with type 2 diabetes mellitus.
  • Its mechanism involves inhibiting renal glucose reabsorption, resulting in enhanced glucose excretion.
  • Administered once daily, Emjard offers convenience and efficacy in managing diabetes.
  • Caution is advised in patients with renal impairment, and regular monitoring ensures optimal therapeutic outcomes.

Emjard 25

400.00৳ Strip
  • Emjard is a medication for adults with type 2 diabetes mellitus.
  • It improves glycemic control when combined with diet and exercise.
  • By inhibiting sodium glucose co-transporter-2 (SGLT-2) in the kidneys:
    • Increases glucose excretion
    • Promotes weight loss
    • Reduces blood pressure
  • Emjard is available in tablet form for once-daily administration, with or without food.
  • Patients should follow recommended dosages and consult healthcare professionals for optimal diabetes management.